Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katerina Saltiki

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 19, 2025
Primary Hyperparathyroidism in MEN2 SyndromesKaterina Saltiki, Maria Alevizaki
Hormones (Athens, Greece)|February 28, 2007
Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptorsKaterina Saltiki, Maria Alevizaki
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|October 24, 2015
Primary Hyperparathyroidism in MEN2 SyndromesMaria Alevizaki, Katerina Saltiki
Endocrinology, Diabetes & Metabolism Case Reports|September 22, 2021
Medullary thyroid carcinoma (MTC): unusual metastatic sitesParaskevi Kazakou, George Simeakis, Maria Alevizaki, et al.
European Journal of Endocrinology|July 27, 2022
MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectivesKaterina Saltiki, George Simeakis, Olga Karapanou, et al.
Endocrine Connections|April 27, 2026
De-Escalation Implementation in Low-Risk Papillary Thyroid Cancer: A Nationwide SurveyGrigoris Efraimidis, Eleni Sazakli, Olga Karapanou, et al.
European Journal of Endocrinology|May 27, 2006
The adrenal gland may be a target of LH action in postmenopausal womenMaria Alevizaki, Katerina Saltiki, Emily Mantzou, et al.
Endocrine-Related Cancer|March 10, 2022
Advanced RAI-refractory thyroid cancer: an update on treatment perspectivesOlga Karapanou, George Simeakis, Barbara Vlassopoulou, et al.
European Thyroid Journal|February 28, 2025
Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for changeGrigoris Effraimidis, Eleni Sazakli, Olga Karapanou, et al.
Endocrine|January 10, 2023
Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistanceKaterina Saltiki, George Simeakis, Olga Karapanou, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 19, 2025
Primary Hyperparathyroidism in MEN2 SyndromesKaterina Saltiki, Maria Alevizaki
Hormones (Athens, Greece)|February 28, 2007
Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptorsKaterina Saltiki, Maria Alevizaki
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|October 24, 2015
Primary Hyperparathyroidism in MEN2 SyndromesMaria Alevizaki, Katerina Saltiki
Endocrinology, Diabetes & Metabolism Case Reports|September 22, 2021
Medullary thyroid carcinoma (MTC): unusual metastatic sitesParaskevi Kazakou, George Simeakis, Maria Alevizaki, et al.
European Journal of Endocrinology|July 27, 2022
MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectivesKaterina Saltiki, George Simeakis, Olga Karapanou, et al.
Endocrine Connections|April 27, 2026
De-Escalation Implementation in Low-Risk Papillary Thyroid Cancer: A Nationwide SurveyGrigoris Efraimidis, Eleni Sazakli, Olga Karapanou, et al.
European Journal of Endocrinology|May 27, 2006
The adrenal gland may be a target of LH action in postmenopausal womenMaria Alevizaki, Katerina Saltiki, Emily Mantzou, et al.
Endocrine-Related Cancer|March 10, 2022
Advanced RAI-refractory thyroid cancer: an update on treatment perspectivesOlga Karapanou, George Simeakis, Barbara Vlassopoulou, et al.
European Thyroid Journal|February 28, 2025
Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for changeGrigoris Effraimidis, Eleni Sazakli, Olga Karapanou, et al.
Endocrine|January 10, 2023
Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistanceKaterina Saltiki, George Simeakis, Olga Karapanou, et al.
Pageof 5